Candriam Equities L Biotech.R EUR Acc/ LU1269736838 /
| NAV9/29/2023 | Chg.-2.0100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 286.7300EUR | -0.70% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 10/2/2023 | Public WebStation Live Factsheet | 2023 | English | - |
| 9/11/2023 | Prospectus | 2023 | English | 3,638.77 KB |
| 9/11/2023 | Prospectus | 2023 | German | 3,801.35 KB |
| 6/30/2023 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 6/30/2023 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 3/1/2023 | PREN20230301-0001754721.pdf | 2023 | English | 257.43 KB |
| 3/1/2023 | PRDE20230301-0001709007.pdf | 2023 | German | 265.21 KB |
| 12/31/2022 | Account statment | 2022 | English | 6,504.26 KB |
| 12/31/2022 | Account statment | 2022 | German | 4,696.56 KB |
| 7/2/2022 | Key Investor Information | 2022 | English | 357.53 KB |
| 7/2/2022 | Key Investor Information | 2022 | German | 361.83 KB |